Coal India shares rallied over 3% following plans for a 10% stake sale in subsidiary Mahanadi Coalfields and a positive brokerage note. Adani Green Energy gained 2% after adding 139 MW of solar capacity. Meanwhile, Gland Pharma shares dipped 1% despite receiving a clean USFDA inspection report, as broader market weakness weighed on investor sentiment.
Coal India shares rose over 3% on Wednesday following news that the company has filed for an initial public offering of its subsidiary, Mahanadi Coalfields. The coal giant plans to sell a 10% stake in the subsidiary, a move investors often monitor as it can help unlock value. The stock also received support from a 'buy' rating by brokerage UBS, which set a price target of ₹550 per share, citing strong thermal coal demand. However, investors are also tracking the company's operational performance, as production output reportedly declined by 6% year-on-year in August 2026. This production volatility remains a key factor to watch alongside the ongoing IPO process.
Adani Green Energy shares also climbed 2% on the day. The company confirmed it has operationalized a 139 MW solar facility in Khavda, Gujarat. This addition increases the firm’s total renewable energy generation capacity to 20,280.80 MW. The company also reported an operational battery energy storage system capacity of 3,551 MWh. The expansion at the Khavda project reflects the company's ongoing effort to scale up its clean energy infrastructure, though investors typically watch for execution risks and debt levels associated with such large-scale capital projects.
In contrast to the gains seen in power and utility stocks, Gland Pharma shares fell 1%. This decline occurred despite the company receiving a positive outcome from a recent USFDA inspection. The regulator audited the firm's sterile oncology and API facilities in Visakhapatnam between August 24 and September 1, 2026, and issued zero Form 483 observations, which means no significant regulatory issues were found. While this is a clean report, the stock failed to rise, reflecting a difficult day for the broader market rather than company-specific issues.
Broader market sentiment remained cautious throughout the session, as selling pressure hit several sectors. The Nifty Midcap index fell 1%, while the Nifty Smallcap index retreated 0.6%. With broader indices trading in the red, many stocks struggled to sustain gains despite positive corporate developments. For investors, the next steps include monitoring the official timeline for the Mahanadi Coalfields IPO and tracking the impact of production numbers on Coal India's upcoming financial reports.